3D Bioprinting Market based on by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Research, Clinical), End User (Biopharma, Academia) ,Regional Outlook– Global Forecast up to 2030
Governments throughout the world are launching projects and sponsoring educational institutions, research centres, and research and technology organisations to further investigate and stimulate the development of 3D printing technology. The United States, the United Kingdom, and Canada have all launched government programmes aimed at fostering university-level 3D printing research, accelerating technological innovation, and establishing start-ups. The advent of novel uses for 3D printing has piqued the interest of businesses and governments worldwide. The UK National Strategy for Additive Manufacturing 2023-2030, for example, seeks to reach EUR 3,500 million in gross value added (GVA) per year by 2030, as well as 60,000 employment across industries. The plan represents a comprehensive set of proposals created by workgroups responsible for certain themes.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. COMPONENT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. 3D Bioprinters
5.3. Bioinks
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Research applications
6.3. Clinical applications
7. END USERS: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Research Organizations and Academic Institutes,
7.3. Biopharmaceutical companies
7.4. Hospitals
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. ENVISIONTEC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ORGANOVO HOLDINGS, INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. INVENTIA LIFE SCIENCE PTY LTD
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. POIETIS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. VIVAX BIO, LLC
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ALLEVI
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. CYFUSE BIOMEDICAL K.K.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. 3D BIOPRINTING SOLUTIONS
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. CELLINK GLOBAL
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. REGEMAT 3D S.L.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
TABLE 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
TABLE 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 83. ENVISIONTEC, INC. : FINANCIALS
TABLE 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
TABLE 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
TABLE 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
TABLE 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
TABLE 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
TABLE 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
TABLE 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
TABLE 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
TABLE 92. POIETIS: FINANCIALS
TABLE 93. POIETIS: PRODUCTS & SERVICES
TABLE 94. POIETIS: RECENT DEVELOPMENTS
TABLE 95. VIVAX BIO, LLC: FINANCIALS
TABLE 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
TABLE 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
TABLE 98. ALLEVI: FINANCIALS
TABLE 99. ALLEVI: PRODUCTS & SERVICES
TABLE 100. ALLEVI: RECENT DEVELOPMENTS
TABLE 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
TABLE 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
TABLE 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
TABLE 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
TABLE 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
TABLE 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
TABLE 107. CELLINK GLOBAL: FINANCIALS
TABLE 108. CELLINK GLOBAL: PRODUCTS & SERVICES
TABLE 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
TABLE 110. REGEMAT 3D S.L.: FINANCIALS
TABLE 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
TABLE 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS
CHART. 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
CHART. 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 83. ENVISIONTEC, INC. : FINANCIALS
CHART. 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
CHART. 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
CHART. 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
CHART. 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
CHART. 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
CHART. 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
CHART. 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
CHART. 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
CHART. 92. POIETIS: FINANCIALS
CHART. 93. POIETIS: PRODUCTS & SERVICES
CHART. 94. POIETIS: RECENT DEVELOPMENTS
CHART. 95. VIVAX BIO, LLC: FINANCIALS
CHART. 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
CHART. 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
CHART. 98. ALLEVI: FINANCIALS
CHART. 99. ALLEVI: PRODUCTS & SERVICES
CHART. 100. ALLEVI: RECENT DEVELOPMENTS
CHART. 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
CHART. 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
CHART. 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
CHART. 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
CHART. 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
CHART. 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
CHART. 107. CELLINK GLOBAL: FINANCIALS
CHART. 108. CELLINK GLOBAL: PRODUCTS & SERVICES
CHART. 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
CHART. 110. REGEMAT 3D S.L.: FINANCIALS
CHART. 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
CHART. 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. COMPONENT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. 3D Bioprinters
5.3. Bioinks
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Research applications
6.3. Clinical applications
7. END USERS: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Research Organizations and Academic Institutes,
7.3. Biopharmaceutical companies
7.4. Hospitals
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. ENVISIONTEC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ORGANOVO HOLDINGS, INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. INVENTIA LIFE SCIENCE PTY LTD
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. POIETIS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. VIVAX BIO, LLC
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ALLEVI
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. CYFUSE BIOMEDICAL K.K.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. 3D BIOPRINTING SOLUTIONS
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. CELLINK GLOBAL
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. REGEMAT 3D S.L.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
TABLE 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
TABLE 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 83. ENVISIONTEC, INC. : FINANCIALS
TABLE 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
TABLE 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
TABLE 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
TABLE 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
TABLE 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
TABLE 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
TABLE 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
TABLE 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
TABLE 92. POIETIS: FINANCIALS
TABLE 93. POIETIS: PRODUCTS & SERVICES
TABLE 94. POIETIS: RECENT DEVELOPMENTS
TABLE 95. VIVAX BIO, LLC: FINANCIALS
TABLE 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
TABLE 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
TABLE 98. ALLEVI: FINANCIALS
TABLE 99. ALLEVI: PRODUCTS & SERVICES
TABLE 100. ALLEVI: RECENT DEVELOPMENTS
TABLE 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
TABLE 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
TABLE 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
TABLE 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
TABLE 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
TABLE 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
TABLE 107. CELLINK GLOBAL: FINANCIALS
TABLE 108. CELLINK GLOBAL: PRODUCTS & SERVICES
TABLE 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
TABLE 110. REGEMAT 3D S.L.: FINANCIALS
TABLE 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
TABLE 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS
CHART. 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
CHART. 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
CHART. 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
CHART. 83. ENVISIONTEC, INC. : FINANCIALS
CHART. 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
CHART. 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
CHART. 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
CHART. 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
CHART. 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
CHART. 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
CHART. 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
CHART. 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
CHART. 92. POIETIS: FINANCIALS
CHART. 93. POIETIS: PRODUCTS & SERVICES
CHART. 94. POIETIS: RECENT DEVELOPMENTS
CHART. 95. VIVAX BIO, LLC: FINANCIALS
CHART. 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
CHART. 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
CHART. 98. ALLEVI: FINANCIALS
CHART. 99. ALLEVI: PRODUCTS & SERVICES
CHART. 100. ALLEVI: RECENT DEVELOPMENTS
CHART. 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
CHART. 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
CHART. 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
CHART. 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
CHART. 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
CHART. 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
CHART. 107. CELLINK GLOBAL: FINANCIALS
CHART. 108. CELLINK GLOBAL: PRODUCTS & SERVICES
CHART. 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
CHART. 110. REGEMAT 3D S.L.: FINANCIALS
CHART. 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
CHART. 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS
